Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
+$831M |
| 2 |
Palo Alto Networks
PANW
|
+$348M |
| 3 |
Visa
V
|
+$347M |
| 4 |
Citigroup
C
|
+$296M |
| 5 |
CELG
Celgene Corp
CELG
|
+$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$638M |
| 2 |
EOG Resources
EOG
|
+$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$289M |
| 5 |
JD.com
JD
|
+$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Acadia Pharmaceuticals
ACAD
$4.28B
| $36.3M | 0.04% |
1,097,364
-1,423,960
| -56% | -$47.1M |
|
|
SPN
352
DELISTED
Superior Energy Services, Inc.
SPN
| $36.2M | 0.04% |
2,868,927
-648,059
| -18% | -$8.19M |
|
353
Darling Ingredients
DAR
$4.94B
| $36M | 0.04% |
3,201,739
+843,839
| +36% | +$9.48M |
|
354
BOK Financial
BOKF
$7.18B
| $35.9M | 0.04% |
554,762
+106,195
| +24% | +$6.87M |
|
|
DYAX
355
DELISTED
DYAX CORPORATION
DYAX
| $35.5M | 0.04% |
1,859,297
-435,068
| -19% | -$8.31M |
|
356
GE Aerospace
GE
$293B
| $35.3M | 0.04% |
+292,038
| New | +$35.3M |
|
|
CYT
357
DELISTED
CYTEC INDS INC
CYT
| $35.2M | 0.04% |
476,481
-383,311
| -45% | -$28.3M |
|
|
PETX
358
DELISTED
Aratana Therapeutics, Inc.
PETX
| $35.1M | 0.04% |
4,146,200
+714,413
| +21% | +$6.04M |
|
359
Zurn Elkay Water Solutions
ZWS
$7.82B
| $34.9M | 0.04% |
4,261,071
-246,739
| -5% | -$2.02M |
|
360
Flotek Industries
FTK
$336M
| $34.7M | 0.04% |
346,397
+4,815
| +1% | +$482K |
|
|
DYN
361
DELISTED
Dynegy, Inc.
DYN
| $34.7M | 0.04% |
1,677,930
-1,486,814
| -47% | -$30.7M |
|
362
Neurocrine Biosciences
NBIX
$14.3B
| $34.7M | 0.04% |
871,419
-4,312
| -0.5% | -$172K |
|
|
MDCO
363
DELISTED
Medicines Co
MDCO
| $34.1M | 0.04% |
899,315
+7,027
| +0.8% | +$267K |
|
364
Viatris
VTRS
$12.2B
| $34.1M | 0.03% |
846,954
-1,478,767
| -64% | -$59.5M |
|
365
Wendy's
WEN
$1.92B
| $33M | 0.03% |
3,819,118
+522,056
| +16% | +$4.52M |
|
366
NCR Voyix
VYX
$1.81B
| $33M | 0.03% |
2,363,128
-160
| -0% | -$2.23K |
|
367
Owens Corning
OC
$13B
| $32.7M | 0.03% |
780,024
+502,115
| +181% | +$21M |
|
368
MACOM Technology Solutions
MTSI
$9.7B
| $32.5M | 0.03% |
1,122,211
-2,975
| -0.3% | -$86.2K |
|
369
ManpowerGroup
MAN
$1.78B
| $32.5M | 0.03% |
397,139
-61,144
| -13% | -$5.01M |
|
370
Cencora
COR
$57.7B
| $32.2M | 0.03% |
339,205
+3,060
| +0.9% | +$291K |
|
371
Pembina Pipeline
PBA
$22.1B
| $31.9M | 0.03% |
1,327,528
+4,425
| +0.3% | +$106K |
|
372
Teladoc Health
TDOC
$1.39B
| $31.7M | 0.03% |
+1,423,322
| New | +$31.7M |
|
373
DaVita
DVA
$9.62B
| $31.7M | 0.03% |
438,111
+3,309
| +0.8% | +$239K |
|
374
Skyworks Solutions
SWKS
$11.2B
| $31.3M | 0.03% |
371,473
+367,268
| +8,734% | +$30.9M |
|
|
BLUE
375
DELISTED
bluebird bio
BLUE
| $30.9M | 0.03% |
27,915
-11,226
| -29% | -$12.4M |
|